Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Site Search
Showing 1 - 9 of 9 results
Press Release
|
|
2 min read
Press Release
|
|
5 min read
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
Press Release
|
|
5 min read
Press Release
|
|
3 min read
Early stage researchers, life science entrepreneurs, and companies are encouraged to apply starting May 2
Press Release
|
|
6 min read
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Press Release
|
|
3 min read
Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation
Press Release
|
|
5 min read
Press Release
|
|
3 min read
The CF Foundation Patient Registry collects information on the health status of people with cystic fibrosis who receive care in CF Foundation-accredited care centers and agree to participate in the Registry. This information is used to create CF care guidelines, assist care teams providing care to individuals with CF, and guide quality improvement initiatives at care centers. Researchers also use the Patient Registry to study CF treatments and outcomes and to design CF clinical trials.